← Leaderboards
Amanda A Fox
Ut Southwestern Medical Center
$3,679,471
Attributed
$3,679,471
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $802.8K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,679,471 · 1
By mechanism
R01$3,679,471 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Jyothsna Gattineni$2,491,975
- Thomas J Wang$21,119,622
- Jarett D Berry$3,946,135
- Ambarish Pandey$2,438,022
- Peter Gerhard Christoph Zechner$1,606,728
Others in their field
Other Emerging Leaders on “Clinical Management”
- Leonard Freedman · Leidos Biomedical Research, Inc.$533,250,348
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Lynn Briscoe · Leidos Biomedical Research, Inc.$155,198,391
- Leonard Freedmand · Leidos Biomedical Research, Inc.$98,649,302
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
Clinical ManagementClinical TrialsAngiotensin ReceptorAnesthesiologyArrhythmiaAcute Renal Failure With Renal Papillary NecrosisBiobankBiological MarkersBiologyApplications GrantsBloodBrain Natriuretic PeptideAngiotensin-Converting Enzyme InhibitorsCardiac RehabilitationCardiac Surgery ProceduresCardiologyCardiopulmonary BypassCardiovascular SystemCessation Of LifeChronic Kidney FailureBiometryClinical DataClinical InformaticsCohort
Grant awards (5)
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery$515,993
R01 · FY2023 · HL · contact PI
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery$775,575
R01 · FY2022 · HL · contact PI
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery$787,916
R01 · FY2021 · HL · contact PI
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery$797,215
R01 · FY2020 · HL · contact PI
Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery$802,772
R01 · FY2019 · HL · contact PI